Merck & Co. Inc. buy Guggenheim
Start price
06.11.24
/
50%
€94.60
Target price
06.11.25
€121.00
Performance (%)
-21.04%
End price
07.11.25
€74.70
Summary
This prediction ended on 07.11.25 with a price of €74.70. The prediction for Merck & Co. Inc. disappointed with a performance of -21.04%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €1.58 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -1.331% | -1.331% | 16.760% |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $137.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.40
12.02.25
12.02.25
€110.77
12.02.26
12.02.26
20.14%
13.02.26
13.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24